MedKoo Cat#: 206837 | Name: TMP195
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

TMP195 is a potent and selective class IIa HDAC inhibitor with IC50s of 59 nM, 60 nM, 26 nM and 15 nM for HDAC4, HDAC5, HDAC7 and HDAC9 respectively. TMP195 can reprogram monocytes and macrophages in the tumor into cells able to sustain a robust CD8 T cell-mediated anti-tumoral immune response.

Chemical Structure

TMP195
TMP195
CAS#1314891-22-9

Theoretical Analysis

MedKoo Cat#: 206837

Name: TMP195

CAS#: 1314891-22-9

Chemical Formula: C23H19F3N4O3

Exact Mass: 456.1409

Molecular Weight: 456.43

Elemental Analysis: C, 60.53; H, 4.20; F, 12.49; N, 12.28; O, 10.52

Price and Availability

Size Price Availability Quantity
50mg USD 450.00
100mg USD 750.00
200mg USD 1,250.00
500mg USD 1,950.00
1g USD 3,450.00
2g USD 5,450.00
5g USD 9,650.00
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
TMP195; TMP-195; TMP 195.
IUPAC/Chemical Name
N-(2-methyl-2-(2-phenyloxazol-4-yl)propyl)-3-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzamide
InChi Key
QTCSXAUJBQZZSN-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H19F3N4O3/c1-22(2,17-12-32-20(28-17)14-7-4-3-5-8-14)13-27-19(31)16-10-6-9-15(11-16)18-29-21(33-30-18)23(24,25)26/h3-12H,13H2,1-2H3,(H,27,31)
SMILES Code
O=C(NCC(C1=COC(C2=CC=CC=C2)=N1)(C)C)C3=CC=CC(C4=NOC(C(F)(F)F)=N4)=C3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 456.43 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Cassetta L, Pollard JW. Repolarizing macrophages improves breast cancer therapy. Cell Res. 2017 Apr 21. doi: 10.1038/cr.2017.63. [Epub ahead of print] PubMed PMID: 28429765. 2: Targeting Class IIa HDACs May Suppress Breast Tumors and Metastases. Cancer Discov. 2017 Mar 17. doi: 10.1158/2159-8290.CD-RW2017-053. [Epub ahead of print] PubMed PMID: 28314719. 3: Guerriero JL, Sotayo A, Ponichtera HE, Castrillon JA, Pourzia AL, Schad S, Johnson SF, Carrasco RD, Lazo S, Bronson RT, Davis SP, Lobera M, Nolan MA, Letai A. Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages. Nature. 2017 Mar 16;543(7645):428-432. doi: 10.1038/nature21409. Epub 2017 Mar 8. PubMed PMID: 28273064.